[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590846":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":27,"centralContacts":36,"locations":42,"responsibleParty":56,"collaborators":27,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":60,"sex":66,"minAge":67,"maxAge":27,"enrollmentInfo":68,"targetDuration":27,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":45,"whyStopped":27,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Boryung Pharmaceutical Co., Ltd","INDUSTRY",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Metformin + Dapagliflozin 10mg\u002FPioglitazone 30mg","EXPERIMENTAL","One tablet of Metformin and one tablet of Dapagliflozin 10mg\u002FPioglitazone 30mg administered orally once daily for 24 weeks.",[13,14],"Drug: Metformin","Drug: Dapagliflozin\u002FPioglitazone",{"label":16,"type":17,"description":18,"interventionNames":19},"Metformin + Dapagliflozin 10mg\u002FSitagliptin 100mg","ACTIVE_COMPARATOR","One tablet of Metformin and one tablet of Dapagliflozin 10mg\u002FSitagliptin 100mg administered orally once daily for 24 weeks.",[13,20],"Drug: Dapagliflozin\u002FSitagliptin",[22,28,32],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"DRUG","Metformin","The dosage and dose frequency are maintained as they were before the screening.",[9,16],null,{"type":23,"name":29,"description":30,"armGroupLabels":31,"otherNames":27},"Dapagliflozin\u002FPioglitazone","Dapagliflozin 10mg\u002FPioglitazone 30mg QD",[9],{"type":23,"name":33,"description":34,"armGroupLabels":35,"otherNames":27},"Dapagliflozin\u002FSitagliptin","Dapagliflozin 10mg\u002FSitagliptin 100mg QD",[16],[37],{"name":38,"role":39,"phone":40,"phoneExt":27,"email":41},"Oh","CONTACT","+82 2-708-8000","syoh@boryung.co.kr",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":27,"cosmosGeoPoint":50,"geoPoint":55,"contacts":27},"The Catholic University of Korea, Seoul St. Mary's Hospital","RECRUITING","Seoul","Seocho District","06591","South Korea",{"type":51,"coordinates":52},"Point",[53,54],126.9784,37.566,{"lat":54,"lon":53},{"type":57,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100590846","phase-4-a-phase-iv-clinical-trial-to-compare-the-efficacy-and-safety-of-metforminsodium-glucose-cotransporter-2-inhibitorsglt2-ithiazolidinedione-tzd-in-patients-with-type-2-diabetes-100590846",false,"NCT06972732","A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes","A Randomized, Open-label, Active-controlled, Parallel, Multicenter, Phase IV Clinical Trial to Compare the Efficacy and Safety of Switching Metformin+SGLT2-i+Dipeptidyl Peptidase-4-inhibitor(DPP-4-i) to Metformin+SGLT2-i+TZD in Patients With Type 2 Diabetes","TELOS","Inclusion Criteria:\n\n* Has voluntarily agreed to participate in this clinical trial.\n* Adults over 19 years of age\n* Diagnosed with type 2 diabetes\n\nExclusion Criteria:\n\n* Has severe renal and liver disorders\n* Has type 1 diabetes\n* Those who are participating or have participated in other clinical trials and administered their investigational products within 8 weeks before the screening date for this study\n* Those who are deemed ineligible to participate in the study by the investigator","ALL","19 Years",{"count":69,"type":70},204,"ESTIMATED","INTERVENTIONAL",[73],"PHASE4","This is a randomized, open-label, active-controlled, parallel, multicenter, phase IV clinical study evaluating the efficacy and safety of switching Metformin+SGLT2-i+DPP4-i to Metformin+SGLT2-i+TZD in patients with type 2 diabetes.",[76],"Type 2 Diabetes",[78],"type 2 diabetes","2025-09-11",{"date":81,"type":82},"2025-09-15","ACTUAL",{"date":84,"type":82},"2025-06-11",{"date":86,"type":70},"2026-10-01",{"name":5,"class":6},1]